JUPITER, Fla.--(BUSINESS WIRE)--Envoy Therapeutics Inc., a recently formed drug discovery company, today announced that it has begun a research collaboration with The Scripps Research Institute to identify new drugs for Parkinson’s disease (PD) that have greater efficacy and safety compared to current therapies. Using funding provided by Envoy, scientists at the two organizations will apply Scripps - Florida’s high-throughput screening capabilities to discover compounds that modulate a target protein discovered by Envoy.
